title: PDGF stimulates DNA synthesis in human vascular smooth muscle cells via a novel wortmannin-insensitive phosphatidylinositol 3-kinase.
abstract: The class 1(A) phosphatidylinositol 3-kinase enzymes consist of a number of heterodimeric complexes of regulatory and catalytic subunits and have been implicated in a number of cellular responses. While platelet-derived growth factor (PDGF)-induced chemotaxis of human vascular smooth muscle cells (HVSMC) is inhibited by both wortmannin and LY294002, DNA synthesis is only inhibited by LY294002. Serum-induced DNA synthesis however is inhibited by LY294002, wortmannin and rapamycin. Similarly PDGF-induced protein kinase B (PKB) activation is inhibited by LY294002 but not by wortmannin or rapamycin. In conclusion PDGF-induced DNA synthesis appears to occur through a phosphatidylinositol 3-kinase (PI3-K)-dependent, but wortmannin-insensitive, PKB/Akt pathway.
authors.affiliation: Clinical Pharmacology, Imperial College Faculty of Medicine, National Heart and Lung Institute, St Mary's Campus, Paddington, London W2 1NY, UK. j.lymn@imperial.ac.uk
authors.forename: Joanne S
authors.initials: JS
authors.lastname: Lymn
authors.forename: Karen L
authors.initials: KL
authors.lastname: Gallagher
authors.forename: Gerard F
authors.initials: GF
authors.lastname: Clunn
authors.forename: Sofi E
authors.initials: SE
authors.lastname: Fexby
authors.forename: Mahendra K
authors.initials: MK
authors.lastname: Patel
authors.forename: Alun D
authors.initials: AD
authors.lastname: Hughes
mesh_terms: D000730:Androstadienes / Q000494:pharmacology; D000818:Animals; D002417:Cattle; D004247:DNA / Q000096:biosynthesis*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D020928:Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism*; D000081082:Phosphoinositide-3 Kinase Inhibitors; D010766:Phosphorylation / Q000187:drug effects; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology*; D017346:Protein Serine-Threonine Kinases; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt; D044967:Serum / Q000378:metabolism; D013936:Thymidine / Q000031:analogs & derivatives / Q000378:metabolism; D014316:Tritium; D014443:Tyrosine / Q000378:metabolism; D000077191:Wortmannin
chemical_list: D000730:Androstadienes; D004247:DNA; D004791:Enzyme Inhibitors; D020928:Mitogen-Activated Protein Kinases; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D010982:Platelet-Derived Growth Factor; D017346:Protein Serine-Threonine Kinases; D011518:Proto-Oncogene Proteins; D051057:Proto-Oncogene Proteins c-akt; D013936:Thymidine; D014316:Tritium; D014443:Tyrosine; D000077191:Wortmannin; C494918:AKT1 protein, human